Navigation Links
Jazz Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results
Date:2/13/2008

- Annual Xyrem(R) Net Sales Increase 34 Percent

- Investor Day Scheduled for March 13, 2008

PALO ALTO, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced financial results for the fourth quarter and full year ended December 31, 2007.

Total revenues for the quarter ended December 31, 2007 were $15.5 million, compared to $12.4 million for the quarter ended December 31, 2006. Total revenues for the year ended December 31, 2007 increased 46 percent to $65.3 million, compared to $44.9 million for the year ended December 31, 2006. Xyrem(R) (sodium oxybate oral solution) net sales for the quarter ended December 31, 2007 increased 38 percent to $11.1 million, compared with $8.1 million for the last quarter of 2006. Xyrem net sales for the year ended December 31, 2007 increased 34 percent to $39.0 million, compared with $29.0 million for the year ended December 31, 2006.

"We are very pleased with the momentum we achieved in 2007. Our focus in 2008 will be on execution, including the planned commercial launch of LUVOX(R) CR in the first quarter of 2008 after anticipated FDA approval," said Samuel R. Saks, M.D., Chief Executive Officer. "Our portfolio of development-stage product candidates is making steady progress, and we believe that our development efforts will lead to important new products for patients and caregivers."

Jazz Pharmaceuticals' net loss for the fourth quarter of 2007 was $60.0 million, compared to a net loss of $20.5 million for the fourth quarter of 2006. For the year ended December 31, 2007, the company's net loss was $138.8 million, compared to a net loss of $59.4 million for the year ended December 31, 2006. Net loss for th
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
2. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
3. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
4. Keryx Biopharmaceuticals, Inc. Announces Conference Call to Discuss Strategic Alliance
5. Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan
6. NPS Pharmaceuticals, Inc. Announces an Increase in Tender Offer Price for Its 3.0% Convertible Notes Due 2008 and Extends Expiration Date Until October 17, 2007
7. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
8. Jazz Pharmaceuticals, Inc. Announces Changes to its Board of Directors
9. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Third Quarter 2007 Financial Results on Thursday, October 25, at 8:30 A.M. EDT
11. Jazz Pharmaceuticals, Inc. to Announce Third Quarter 2007 Financial Results on November 6, 2007

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...tive new study, a University of Utah scientist arg...r cause of global warming cannot be stabilized un...ds the equivalent of one new nuclear power plant e...e any substantial near-term departure from recentl... rates," says the new paper by Tim Garrett, an ass...
(Date:11/23/2009)...FirstCall/--PDLBioPharma,Inc.(PDL)(Nasdaq: PDLI )t...09astheex-dividenddateforits$200millionspecialdivi...ansactioncompletedonNovember2,2009.Thedividendwill...therecorddate,December1,2009.NASDAQhassettheapprox...ommonstockforpurposesoftheex-dividenddateonNovembe...
(Date:11/23/2009)...gnC or p.(IDC)announcedtodaythatDr.BruceL.A.Carter...ssfultrackrec or dinbiotechnologyexecutivemanageme...tics,inSeattle,WAandChiefScientificOfficeratNovoN ...ww.newscom.com/cgi-bin/prnh/20091123/SF15228 ) ,...cercommented,"IamdelightedtowelcomeDr.BruceCartera...
(Date:11/23/2009)...--CornerstoneTherapeuticsInc.(Nasdaq: CRTX ),aspec...opingandcommercializingsignificantproductsprimaril...thatCraigA.Collard,PresidentandChiefExecutiveOffic...alPiperJaffrayHealthCareConferenceat3:30PMETonWedn...rkCity. ,, AliveaudioandarchivedwebcastofCorner...
Breaking Biology Technology:Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4PDL BioPharma Announces Ex-Dividend Date of November 27 for Special Dividend 2Immune Design Corp. Announces Appointment of Dr. Bruce L.A. Carter as Executive Chairman and Director 2Cornerstone Therapeutics to Present at the 21st Annual Piper Jaffray Health Care Conference 2
...ich., Dec. 28 Perrigo Company,(Nasdaq: PRGO ; TA...roval,from the U.S. Food and Drug Administration f... over-the-counter (OTC) Cetirizine Hydrochloride,T...d under store brand labels and is comparable,to Mc...e Tablets, 5 and 10,mg, which will be marketed as ...
...eting vote suggests broad stockholder support for ...ger, SOUTH SAN FRANCISCO, Calif., Dec. 27 VaxGen...pany, announced today that,its stockholders approv...by,a margin of nearly 3 to 1 in favor with approxi... VaxGen to reverse split its stock in a ratio of 4...
...RDALE, Fla., Dec. 27 Imaging,Diagnostic Systems, ...r,optical breast cancer imaging systems, announced...ve Officer and Director effective January 1, 2008....40412/IMDSLOGO ), Tim Hansen was appointed IDSI ...any by the Board of Directors in July 2004. Mr. Ha...
Other Biology Technology:Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets 2VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal 2VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal 3VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal 4Imaging Diagnostic Systems CEO Announces Retirement 2Imaging Diagnostic Systems CEO Announces Retirement 3
(Date:11/23/2009)...ern California biomedical engineer and cardiologis...o help clinicians distinguish cardiac emergencies ...manageable with drugs and lifestyle change. , An...he arteries feeding the heart, offer an inside vie... vessels, often revealing deposits of a dangerous ...
(Date:11/23/2009)... and toads have existed for 360 million years and ...tic fungus is threatening to make many of them ext...e of Microbiology Today . , The fungus, Batra...ssociated with waves of amphibian extinctions in C...1990,s. Bd infects over 350 amphibian species by p...
(Date:11/23/2009)...e of General Medical Sciences (NIGMS), part of the... $42.3 million for grants in scientific areas it i...oped the GO grant program to stimulate biomedical ...he American Recovery and Reinvestment Act (Recover...ise to have a significant impact on a field of bio...
Breaking Biology News(10 mins):Stable plaque or heart attack plaque? USC researcher builds new sensor to tell which is which 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 3Environmental Chemicals May Affect Male Reproduction 58306 1Environmental Chemicals May Affect Male Reproduction 58306 2Dynatronics Expands Nationwide Direct Sales Force by 25 Percent 58304 1Dynatronics Expands Nationwide Direct Sales Force by 25 Percent 58304 2Saint Louis Public School District Awards Contract to Accelify 58302 1Saint Louis Public School District Awards Contract to Accelify 58302 2
...institutional study led by Cincinnati Childrens Ho...ticularly stubborn solid tumor cancers neuroblast...ming healthy tissues by inserting instructions to ...cording to study results published in the February...e still very difficult to treat effectively, espec...
...erwater Sound , Connie Barclay, NOAA Fisheries, (...oking at how marine mammals react to underwater so...o intense underwater sound in some settings may ca...y die. Some of these strandings are associated wit...ost have involved beaked whales; the dominant spec...
...enome of a one-celled, planktonic marine organism,... Nature, is already telling scientists about the e... one-celled life forms to multicellular animals li...entary Science paper also released this week, Univ...King, Daniel Rokhsar and their colleagues present ...
Other Biology News:Tumor-targeting viral therapy slows neuroblastoma, malignant peripheral nerve sheath tumors 2NOAA science story tips -- AAAS 2008 edition 2NOAA science story tips -- AAAS 2008 edition 3NOAA science story tips -- AAAS 2008 edition 4NOAA science story tips -- AAAS 2008 edition 5NOAA science story tips -- AAAS 2008 edition 6NOAA science story tips -- AAAS 2008 edition 7Genome of marine organism tells of humans' unicellular ancestors 2Genome of marine organism tells of humans' unicellular ancestors 3Genome of marine organism tells of humans' unicellular ancestors 4
Goat Anti-Human Rabenosyn 5 Polyclonal Antibody, Unconjugated from Abcam
Anti-Acetyl CoA Carboxylase Antibody, Unconjugated from Cell Signaling Technology
Rabbit Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119] NON-neutralizing Polyclonal Antibody, Unconjugated from Cell Sciences
Anti-AANAT Antibody, Unconjugated from CHEMICON
Biology Products: